Physician profile
James E Fullwood
NPI 1184936643
$16,986.68
in general payments reported to CMS, 2019-2025
13 companies · $5,299 in 2025
The $5,299 reported for 2025 was more than what 94% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,843 · 2020: $1,257 · 2021: $2,688 · 2023: $539 · 2024: $4,362 · 2025: $5,299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,423 · Food and Beverage: $2,776.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,423.16 |
| Food and Beverage | $2,776.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $6,185.70 | 2019-2025 | Trabecular Metal |
| Arthrex, INC. | $2,754.20 | 2021-2025 | |
| Stryker Corporation | $2,648.78 | 2019-2025 | Inbone, Infinity |
| Lifenet Health | $2,109.11 | 2025 | Theragenesis Wound Matrix |
| Kairos Surgical INC | $1,237.00 | 2020-2023 | |
| Powerlink Ai, INC. | $752.35 | 2025 | |
| Organogenesis INC. | $728.60 | 2019-2023 | Puraply |
| Paratek Pharmaceuticals, INC. | $249.53 | 2025 | Nuzyra |
| Paragon 28, INC. | $161.29 | 2025 | Portfolio, Ankle Fracture |
| Trilliant Surgical LLC. | $53.50 | 2019 | |
| Djo, LLC | $49.71 | 2023 | Dr Comfort |
| Integra Lifesciences Corporation | $33.62 | 2020 | |
| Mimedx Group, INC. | $23.29 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Fullwood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.